Tender

NHS National Generics Pharmaceuticals - Supply Chain Resilience

  • NHS England

UK4: Tender notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2026/S 000-008328

Procurement identifier (OCID): ocds-h6vhtk-060abf (view related notices)

Published 30 January 2026, 10:15am

Last edited 30 January 2026, 11:36am

Show all versions Hide all versions


This is an old version of this notice. View the latest version.

Scope

Reference

CM/PHG/25/5739

Description

NHS National Generics Pharmaceuticals - Supply Chain Resilience

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Periods of call-offs under the framework agreement:

CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products

CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)

NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)

LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

CM/PHG/25/5739/02 - Hospital Only Products

DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)

DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)

DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Commercial tool

Establishes a framework

Total value (estimated)

  • £52,447,296 excluding VAT
  • £62,936,755 including VAT

Above the relevant threshold

Contract dates (estimated)

  • 1 September 2026 to 31 May 2028
  • Possible extension to 31 August 2030
  • 4 years

Description of possible extension:

Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Options

The right to additional purchases while the contract is valid.

Option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UKC - North East (England)
  • UKD - North West (England)
  • UKE - Yorkshire and the Humber
  • UKF - East Midlands (England)
  • UKG - West Midlands (England)
  • UKH - East of England
  • UKI - London
  • UKJ - South East (England)
  • UKK - South West (England)

Lot 1. Lot 1 - CM/PHG/25/5739/01 - Oral (plus non-parenteral) products

Description

CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products

CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)

NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)

LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

Lot value (estimated)

  • £10,229,220 excluding VAT
  • £12,275,064 including VAT

Framework lot values may be shared with other lots

Same for all lots

CPV classifications, contract locations, contract dates and options are shown in the Scope section, because they are the same for all lots.


Lot 2. Lot 2 - CM/PHG/25/5739/02 - Hospital only products

Description

CM/PHG/25/5739/02 - Hospital Only Products

DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)

DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)

DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Lot value (estimated)

  • £42,218,076 excluding VAT
  • £50,661,691 including VAT

Framework lot values may be shared with other lots

Same for all lots

CPV classifications, contract locations, contract dates and options are shown in the Scope section, because they are the same for all lots.


Framework

Maximum number of suppliers

Unlimited

Maximum percentage fee charged to suppliers

0%

Framework operation description

Please refer to the ITO Documents for the Operation Description

Award method when using the framework

With competition

Contracting authorities that may use the framework

Please refer to Document No. 09 in the

ITO Documents for the list of

Purchasing Points.


Participation

Particular suitability

Lot 1. Lot 1 - CM/PHG/25/5739/01 - Oral (plus non-parenteral) products

Lot 2. Lot 2 - CM/PHG/25/5739/02 - Hospital only products

Small and medium-sized enterprises (SME)


Submission

Enquiry deadline

23 February 2026, 5:00pm

Tender submission deadline

2 March 2026, 1:00pm

Submission address and any special instructions

The procurement documents are

available for unrestricted and full direct

access, free of charge at https://health-family.force.com/s/Welcome

Additional information may be obtained

from the abovementioned address.

Tenders must be submitted to the

above mentioned address.

Tenders may be submitted electronically

Yes

Languages that may be used for submission

English

Award decision date (estimated)

1 May 2026


Award criteria

This table displays the award criteria of the lot
Name Description Type
Price

Price is not the only award criterion and all criteria are stated in the procurement documentation

Price

Weighting description

Price is not the only award criterion and all criteria are stated only in the procurement documents.


Other information

Applicable trade agreements

  • Government Procurement Agreement (GPA)

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Open procedure


Documents

Associated tender documents

CM_PHG_25_5739 Supply Chain resilience tender docs.zip


Contracting authority

NHS England

  • Public Procurement Organisation Number: PDPT-3135-BWWY

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

United Kingdom

Contact name: David Ford

Email: david.ford1@nhs.net

Website: https://www.england.nhs.uk/

Region: UKI45 - Lambeth

Organisation type: Public authority - central government